Amatoxin: Physiology and What Research Reports
Amatoxins are small cyclic peptides made by several mushroom genera, most famously Amanita phalloides. Published reviews describe them as inhibitors of RNA polymerase II that damage liver cells after a characteristically delayed onset of symptoms. This page summarises what the literature reports about where amatoxins occur, how they move through the body, how laboratories detect them, and what treatment studies have examined — including N-acetylcysteine reviews, enterohepatic-circulation interruption, and therapeutic plasma exchange. It is educational only and contains no guidance for use.
Amatoxins are a family of bicyclic peptides — eight amino acids arranged in a cross-linked ring — produced by certain mushrooms. The best known member is α-amanitin, found in Amanita phalloides (the death cap). Reviews of amatoxin mushroom toxicity describe these peptides as the compounds responsible for the majority of fatal mushroom poisonings worldwide, acting primarily on the liver (PMID 28613706). This page is for educational purposes only and is not medical advice; consult a licensed physician for any question about exposure, symptoms, or treatment.
What Is Amatoxin?
The term "amatoxin" refers to a chemical class rather than a single molecule. Members include α-amanitin, β-amanitin, γ-amanitin and related congeners. Structurally they are peptides, which is why the word appears in peptide-chemistry discussions: they are among the most-studied naturally occurring cyclic peptide toxins, stable to heat and to cooking, and not destroyed by drying. Reviews of amatoxin-containing mushroom poisonings grouped these compounds together because they share a common toxidrome and a common molecular target (PMID 29325729).
Two related toxin families often appear alongside amatoxins in the same mushrooms — phallotoxins and virotoxins — but published reviews attributed the delayed, liver-centred illness specifically to the amatoxins (PMID 28613706).
Where Amatoxins Are Produced
Amatoxins are not confined to one genus. A survey of species, toxidromes, treatments and outcomes reported that amatoxin-containing mushrooms span multiple genera rather than Amanita alone (PMID 29325729). A mycological analysis of the wood-rotting species Galerina marginata reported amatoxin content in that fungus, extending the known distribution beyond the classic death-cap group (PMID 21148893). A later phytochemical study examined the occurrence of amatoxins across Lepiota species and used the results for chemotaxonomical analysis, reporting that amatoxin presence varied between species within the genus (PMID 34965486).
That distribution matters scientifically: because morphologically unrelated small brown mushrooms can carry the same peptide toxins, chemical detection — not appearance — determines whether a specimen contains amatoxin.
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeHow Amatoxins Act in the Body
Reviews describe a well-defined molecular mechanism. Amatoxins are taken up by hepatocytes and inhibit RNA polymerase II, halting messenger-RNA transcription and therefore protein synthesis, which leads to cell death in tissues with high transcriptional demand — chiefly the liver, with secondary kidney involvement (PMID 28613706). Because the toxin acts on transcription rather than on a receptor, the injury progresses over hours to days after the peptide has already been absorbed.
A second feature repeatedly discussed in the literature is enterohepatic circulation: amatoxin is secreted in bile and reabsorbed from the gut, which prolongs hepatic exposure. A 2024 clinical-toxicology study examined the effects of interrupting the enterohepatic circulation in amatoxin intoxications and reported on this strategy as a management approach in analysed cases (PMID 38411174).
Toxicokinetics in Animal Work
A 2024 toxicokinetic study administered α-amanitin and β-amanitin to mice as single agents and in combination, and researchers reported the resulting toxicokinetic profiles with the aim of simulating how mixtures of amatoxins behave in clinical cases (PMID 38971475). The study's premise — that real exposures involve more than one congener at once — is a recurring theme in amatoxin pharmacology.
The Clinical Course: What Studies Report
The amatoxin toxidrome described in reviews is notable for its delay. Published summaries reported a latent period of several hours after ingestion before gastrointestinal symptoms appear, followed by an apparent improvement, and then evidence of hepatic injury that can progress to acute liver failure (PMID 28613706). The Wilderness & Environmental Medicine review of amatoxin-containing mushroom poisonings catalogued toxidromes and outcomes across implicated species and reported that outcomes varied with presentation and management (PMID 29325729).
Tracking research? Log entries with dates, lots and notes — records, never plans.
Get the appAmatoxin Exposure: What Studies Report
The adverse-effect profile in the literature is the toxidrome itself. Reviews reported vomiting and diarrhoea in the early phase, transaminase elevation and coagulopathy as hepatic injury develops, renal involvement in some cases, and progression to acute liver failure in severe intoxications (PMID 28613706, PMID 29325729). A multi-centre study of therapeutic plasma exchange was conducted specifically in amatoxin-associated acute liver failure, reflecting how severe the endpoint can be in the population studied (PMID 41163058). No safe or tolerable exposure level for amatoxin is described in the papers reviewed here.
How Amatoxins Are Measured
Detection has two settings: identifying toxin in a suspect mushroom, and identifying it in a patient sample. Researchers developed a lateral flow immunoassay (LFIA) for the detection of lethal amatoxins from mushrooms and reported that the format allowed rapid testing outside a specialised laboratory (PMID 32302363). Analytical chemistry methods underpin research work: the mouse toxicokinetic study relied on quantification of α- and β-amanitin in biological samples to build its profiles (PMID 38971475), and chemotaxonomical work on Lepiota used chemical analysis of fruiting bodies to establish which species contained amatoxins (PMID 34965486).
Want the full course? Every compound, evidence-graded and cited, inside PeptideU.
Start learning freeWhat the Treatment Literature Examines
Several distinct research lines appear in the verified literature, and none of them is summarised here as guidance.
| Research line | What was studied | Source |
|---|---|---|
| N-acetylcysteine | A systematic review assessed N-acetylcysteine as a treatment for amatoxin poisoning and reported on the quality and consistency of the available evidence | PMID 32609548 |
| Enterohepatic interruption | Researchers examined the effects of interrupting the enterohepatic circulation in amatoxin intoxications | PMID 38411174 |
| Therapeutic plasma exchange | The multi-centre Amanita-PEX study reported results of therapeutic plasma exchange in amatoxin-associated acute liver failure | PMID 41163058 |
| Historical case series | A 20-year retrospective analysis compiled reported treatments of amatoxin poisoning and their documented outcomes | PMID 12475187 |
The 20-year retrospective analysis of treatment of amatoxin poisoning remains one of the largest published compilations of case data, and researchers reported that treatment practice was heterogeneous across the cases reviewed (PMID 12475187).
Why the Term Appears in Peptide Reading
Amatoxin is a peptide, and readers moving through peptide literature encounter it for three reasons. First, it is a textbook example of how a small constrained cyclic peptide can be extraordinarily potent and metabolically stable. Second, it illustrates transporter-mediated tissue targeting — the concentration of effect in hepatocytes described in toxicity reviews (PMID 28613706). Third, it is a reminder that "peptide" describes chemistry, not safety: the same structural class includes hormones, signalling fragments and lethal toxins.
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeLimits of the Evidence
- Human data are dominated by case series and retrospective analyses rather than randomised trials (PMID 12475187).
- The systematic review of N-acetylcysteine assessed a literature built largely on reported cases rather than controlled comparisons (PMID 32609548).
- Toxicokinetic detail comes from animal work, and the mouse study framed its combined-administration design as a simulation of clinical exposure rather than a direct measurement in humans (PMID 38971475).
- Species distribution continues to be revised as chemical surveys examine new genera (PMID 34965486, PMID 21148893).
Nothing on this page describes a protocol, and amatoxin is a poison studied in toxicology, not a research compound with any described beneficial application in the papers cited here.
References
- Amatoxin Mushroom Toxicity (StatPearls, 2026)
- Amatoxin-Containing Mushroom Poisonings: Species, Toxidromes, Treatments, and Outcomes (Wilderness & Environmental Medicine, 2018)
- Occurrence and chemotaxonomical analysis of amatoxins in Lepiota spp. (Agaricales) (Phytochemistry, 2022)
- Amatoxins in wood-rotting Galerina marginata (Mycologia, 2004)
- N-acetylcysteine as a treatment for amatoxin poisoning: a systematic review (Clinical Toxicology, 2020)
- Effects of interrupting the enterohepatic circulation in amatoxin intoxications (Clinical Toxicology, 2024)
- Therapeutic plasma exchange in amatoxin associated acute liver failure - results from the multi-center Amanita-PEX study (Critical Care, 2025)
- Treatment of amatoxin poisoning: 20-year retrospective analysis (Journal of Toxicology. Clinical Toxicology, 2002)
- Lateral flow immunoassay (LFIA) for the detection of lethal amatoxins from mushrooms (PLoS One, 2020)
- Toxicokinetics of α- and β-amanitin in mice following single and combined administrations (Toxicon, 2024)
Frequently asked questions
What is amatoxin?▾
Amatoxin is the name for a family of bicyclic peptide toxins — including α-amanitin and β-amanitin — produced by certain mushrooms. Toxicity reviews describe them as inhibitors of RNA polymerase II that block messenger-RNA transcription and damage liver cells, and they are reported as the toxins responsible for most fatal mushroom poisonings (PMID 28613706, PMID 29325729).
Which mushrooms contain amatoxins?▾
Amanita species such as the death cap are the classic source, but the literature reports a wider distribution. Researchers documented amatoxins in the wood-rotting fungus Galerina marginata (PMID 21148893), and a chemotaxonomical study reported that amatoxin occurrence varied across Lepiota species (PMID 34965486). A review catalogued the species implicated in amatoxin poisonings (PMID 29325729).
Why are amatoxin symptoms delayed?▾
Amatoxins act on transcription rather than on a fast receptor pathway, so injury accumulates. Reviews reported a latent period of several hours before gastrointestinal symptoms, then an apparent improvement, then laboratory and clinical evidence of liver injury that can progress to acute liver failure (PMID 28613706, PMID 29325729). That delay is why case reviews stress the exposure history.
How is amatoxin detected?▾
Two approaches appear in the literature. Researchers developed a lateral flow immunoassay to detect lethal amatoxins in mushroom material and reported it as a rapid format usable outside a specialised laboratory (PMID 32302363). Analytical quantification of α- and β-amanitin in biological samples underpinned a mouse toxicokinetic study (PMID 38971475), and chemical analysis supported species surveys (PMID 34965486).
What treatments has the literature studied?▾
Published work examined several approaches without establishing a single standard. A systematic review assessed N-acetylcysteine as a treatment for amatoxin poisoning (PMID 32609548); a 2024 study examined interrupting the enterohepatic circulation (PMID 38411174); the multi-centre Amanita-PEX study reported results of therapeutic plasma exchange in amatoxin-associated acute liver failure (PMID 41163058); and a 20-year retrospective analysis compiled reported case treatments (PMID 12475187).
What does enterohepatic circulation mean for amatoxin?▾
Amatoxin secreted into bile can be reabsorbed from the intestine, returning it to the liver and prolonging exposure. Researchers examined the effects of interrupting this cycle in amatoxin intoxications and reported on it as a management strategy in the cases analysed (PMID 38411174). Reviews describe the liver as the principal target tissue (PMID 28613706).
Is amatoxin used as a research peptide?▾
In the papers summarised here, amatoxin appears only as a toxin studied in toxicology, mycology and analytical chemistry — not as a compound with any described beneficial application. Animal work used it to characterise toxicokinetics of α- and β-amanitin given singly and in combination (PMID 38971475). This answer is educational only and is not medical advice.
Track it. Calculate it. Actually understand it.
References
This page summarises published research for education — it is not medical advice, and nothing here is a recommendation to use, purchase, or dose any substance. Study parameters described are what researchers reported, not instructions. Consult a qualified clinician before any health decision.